Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus.
about
Megalin/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: implications for PPARs' roles in renal functionOpposite action of peroxisome proliferator-activated receptor-gamma in regulating renal inflammation: functional switch by its ligandEffects of sildenafil and/or muscle derived stem cells on myocardial infarction.Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease.Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitorMultiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress.Renal interstitial fibrosis: mechanisms and evaluation.Combination therapy with losartan and pioglitazone additively reduces renal oxidative and nitrative stress induced by chronic high fat, sucrose, and sodium intake.Implanted Muscle-Derived Stem Cells Ameliorate Erectile Dysfunction in a Rat Model of Type 2 Diabetes, but Their Repair Capacity Is Impaired by Their Prior Exposure to the Diabetic Milieu.Pioglitazone Inhibits the Expressions of p22(phox) and p47(phox) in Rat Mesangial Cells In Vitro.The Nrf2 pathway in the progression of renal disease.Pharmacologic targets and peritoneal membrane remodeling.Renal allograft fibrosis: biology and therapeutic targets.Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.Ferric carboxymaltose-mediated attenuation of Doxorubicin-induced cardiotoxicity in an iron deficiency rat model.Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis.PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.Effects of the dual PPAR-α/γ agonist aleglitazar on glycaemic control and organ protection in the Zucker diabetic fatty rat.Nitrosative stress and apoptosis in non-anemic healthy rats induced by intravenous iron sucrose similars versus iron sucrose originator.The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice
P2860
Q27437610-ECA08CBD-BEFE-4A21-BB5D-FC1873CAF499Q28581020-3EE4A0B1-3055-49E4-B25B-DC5698F3FDF1Q30462352-02AABA40-4F9C-4E35-93DC-CFD8E7B7EEA2Q34260759-1D43B5F9-D43A-4DC7-B8CD-5255B635455BQ34962806-0AC2E4AF-D8FE-4F12-9B33-2671E8A41F21Q35126070-41479C79-F453-4B39-B40A-B2B24F2B58EDQ35967489-96FCBDBE-C012-41D8-891C-D0D266F7483AQ36421284-0C4FECC5-B5E8-4761-81A4-F91C8D45EE9DQ36951110-F08444D5-109D-4EFD-B4C4-565390EC1076Q37594599-B498E3CF-0FF0-48C0-BDE0-DE8107FC12C4Q38114031-61A991F0-18B9-4F45-83DC-9B8F800C2B0BQ38187841-2FD318B2-2472-4CFA-B1DC-7908ABC8F0D1Q38359455-6ACB7F69-2AF9-4552-B0AE-C9676CC4F5D9Q38840585-2671E549-44D3-4278-A873-E68E68C65346Q39642839-47C9EE04-207E-42F5-9776-7E295EBA0708Q42707950-0BF1C4BE-367D-4FAB-A9A4-86F943BD7D99Q43040958-35F12295-70D0-45C9-AC81-6B53A19D2EDBQ43218265-CDF0FFCF-B778-40E6-BAC3-AD7CE3807181Q44692555-DAE412DE-2F07-4D72-AE07-3CEB0FC66CE9Q46783918-3ED18A9D-6466-4834-A6F6-488489F637C3Q57212511-ACB1657C-9734-4DBA-A2C0-7CC0120E82C9
P2860
Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antifibrotic effects of piogli ...... l of type 2 diabetes mellitus.
@en
Antifibrotic effects of piogli ...... l of type 2 diabetes mellitus.
@nl
type
label
Antifibrotic effects of piogli ...... l of type 2 diabetes mellitus.
@en
Antifibrotic effects of piogli ...... l of type 2 diabetes mellitus.
@nl
prefLabel
Antifibrotic effects of piogli ...... l of type 2 diabetes mellitus.
@en
Antifibrotic effects of piogli ...... l of type 2 diabetes mellitus.
@nl
P2093
P2860
P356
P1476
Antifibrotic effects of piogli ...... l of type 2 diabetes mellitus.
@en
P2093
Dolores Vernet
Gabriel Cao
Jorge E Toblli
Margarita Angerosa
Monica G Ferrini
Nestor F Gonzalez-Cadavid
P2860
P304
P356
10.1093/NDT/GFP103
P407
P577
2009-03-17T00:00:00Z